相似文献
1
A Response Letter to: Letter to the Editor Regarding "Anti-SARS-CoV-2 Vaccination Related Polyradiculitis Requires Early Diagnosis and Treatment to Improve the Outcome: Facts and Challenges During COVID-19 Pandemic".
Pulm Ther. 2023 Sep;9(3):455-457. doi: 10.1007/s41030-023-00236-w. Epub 2023 Jul 24.
2
Letter to the Editor: Anti-SARS-CoV-2 Vaccination-Related Polyradiculitis Requires Early Diagnosis and Treatment to Improve the Outcome.
Pulm Ther. 2023 Sep;9(3):451-453. doi: 10.1007/s41030-023-00237-9. Epub 2023 Jul 24.
3
Letter to the Editor: SARS-CoV-2-Related Polyradiculitis Requires Exclusion of Alternative Causes and Long-Term Follow-up.
J Korean Med Sci. 2024 May 27;39(20):e181. doi: 10.3346/jkms.2024.39.e181.
4
Letter to the editor: Increase of influenza vaccination coverage rates during the COVID-19 pandemic and implications for the upcoming influenza season in northern hemisphere countries and Australia.
Euro Surveill. 2021 Dec;26(50). doi: 10.2807/1560-7917.ES.2021.26.50.2101143.
5
COVID-19 and vaccination rollout in Fiji: Challenges caused by digital platform.
Int J Surg. 2021 Jul;91:106001. doi: 10.1016/j.ijsu.2021.106001. Epub 2021 Jun 18.
6
Letter to the Editor Regarding: What Triggers Takotsubo After a SARS-CoV-2 Vaccination? Heart Lung Circ. 2021;30(12):e119-20.
Heart Lung Circ. 2022 May;31(5):e76-e77. doi: 10.1016/j.hlc.2021.12.010. Epub 2022 Jan 19.
7
Severe rhabdomyolysis and SARS-CoV-2 vaccination: a reply to the letter by Dr. Josef Finsterer.: Reply to Letter to the Editor regarding our report to Dr. Finsterer.
Int J Infect Dis. 2022 Sep;122:1005. doi: 10.1016/j.ijid.2022.06.036. Epub 2022 Jun 26.
8
Response to Letter to the Editor on the article "Acute disseminated encephalomyelitis after SARS-CoV-2 vaccination".
Clin Neurol Neurosurg. 2022 Feb;213:107129. doi: 10.1016/j.clineuro.2022.107129. Epub 2022 Jan 15.
9
Letter to the editor: Wide indication for SARS-CoV-2-testing allowed identification of international risk areas during the early phase of the COVID-19 pandemic in Germany.
Euro Surveill. 2020 Jun;25(23). doi: 10.2807/1560-7917.ES.2020.25.23.2001119.
10
Response to the letter to the editor: two cases of subacute thyroiditis after different types of SARS-CoV-2 vaccination.
Arch Endocrinol Metab. 2022 Nov 17;66(6):932-933. doi: 10.20945/2359-3997000000569.
引用本文的文献
1
Letter to the Editor: Anti-SARS-CoV-2 Vaccination-Related Polyradiculitis Requires Early Diagnosis and Treatment to Improve the Outcome.
Pulm Ther. 2023 Sep;9(3):451-453. doi: 10.1007/s41030-023-00237-9. Epub 2023 Jul 24.
本文引用的文献
1
Effects of COVID-19 vaccine type on Guillain-Barré syndrome: Two cases and a literature review.
Hum Vaccin Immunother. 2023 Dec 31;19(1):2171231. doi: 10.1080/21645515.2023.2171231. Epub 2023 Feb 22.
2
Guillain-Barré Syndrome in Patient With SARS-CoV-2 PCR Positivity Treated Successfully With Therapeutic Exchange Plasma: A First Case Report From Vietnam.
Front Neurol. 2022 May 25;13:868667. doi: 10.3389/fneur.2022.868667. eCollection 2022.
3
Early diagnosis and treatment of SARS-CoV-2 vaccination associated polyradiculitis improves outcome.
Vacunas. 2022 Sep-Dec;23:S123-S124. doi: 10.1016/j.vacun.2022.05.003. Epub 2022 Jun 3.
4
Sensory Guillain-Barre syndrome following the ChAdOx1 nCov-19 vaccine: Report of two cases and review of literature.
J Neuroimmunol. 2021 Oct 15;359:577691. doi: 10.1016/j.jneuroim.2021.577691. Epub 2021 Aug 8.
5
Significance of Brighton Criteria in the Early Diagnosis and Management of Guillain-Barré Syndrome.
Cureus. 2020 May 27;12(5):e8318. doi: 10.7759/cureus.8318.
6
Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria.
Brain. 2014 Jan;137(Pt 1):33-43. doi: 10.1093/brain/awt285. Epub 2013 Oct 26.
Zotero 插件